Core Viewpoint - The company, Shuyupingmin (301017.SZ), announced that its controlling shareholder, actual controller, and chairman, Mr. Li Wenjie, plans to reduce his shareholding through block trading from August 28, 2025, to November 27, 2025, by a maximum of 8.0473 million shares, accounting for 2% of the company's total share capital [1] Summary by Category - Shareholding Reduction Plan - The controlling shareholder intends to reduce his stake in the company by up to 8.0473 million shares [1] - This reduction represents 2% of the total share capital of the company [1] - Timeline for Reduction - The planned reduction will occur between August 28, 2025, and November 27, 2025 [1]

| 证券代码：301017 | 证券简称：漱玉平民 | 公告编号：2025-068 | | --- | --- | --- | | 债券代码：123172 | 债券简称：漱玉转债 | | 漱玉平民大药房连锁股份有限公司 关于控股股东、实际控制人、董事长减持股份预披露的公告 公司控股股东、实际控制人、董事长李文杰先生保证向本公司提供的信息内容真实、准确、 完整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 特别提示 1、漱玉平民大药房连锁股份有限公司（以下简称"公司"或"发行人"）控股股东、实 际控制人、董事长李文杰先生持有公司股份 142,560,000 股（占公司总股本比例为 35.43%）， 计划在本公告发布之日起 15 个交易日后的 3 个月内（即 2025 年 8 月 28 日至 2025 年 11 月 27 日），以大宗交易方式共计减持本公司股份不超过 8,047,279 股，占公司总股本的 2%。 3、减持股份数量及比例：李文杰先生拟减持的股份合计不超过 8,047,279 股，占公司 总股本的比例为 2%，其中通过大宗交易方式合计减持不 ...

Core Viewpoint - The company acknowledges the potential growth opportunities in the pharmaceutical retail market due to policy changes and demographic trends, particularly the aging population and health consumption upgrades [1]. Group 1: Policy Impact - The company highlights that the implementation of prescription outflow policies varies across regions, which will have a significant long-term impact on sales performance, customer traffic, and multi-category development in the pharmaceutical retail industry [1]. - The company is committed to closely monitoring national and local policy dynamics and trends to adapt its strategies accordingly [1]. Group 2: Market Opportunities - The company aims to actively position itself to seize structural opportunities in the industry driven by accelerated population aging, continuous health consumption upgrades, and deepening reforms in the pharmaceutical sector [1].

Core Viewpoint - The company is positioned to leverage the benefits of prescription drug outflow policies and aims to capitalize on opportunities in the pharmaceutical retail market driven by aging population and health consumption upgrades [1] Group 1: Company Strategy - The company acknowledges the varying implementation details and progress of prescription outflow policies across different regions [1] - The company plans to closely monitor national and local policy dynamics and trends to adapt its strategies accordingly [1] - The company is committed to actively positioning itself to seize structural opportunities in the industry amid multiple driving factors such as accelerated aging population and ongoing health consumption upgrades [1] Group 2: Industry Outlook - The deepening implementation of prescription outflow policies is expected to have a profound impact on sales performance, customer traffic, and multi-category collaborative development in the pharmaceutical retail industry [1]

Core Viewpoint - The company is leveraging national policies and strategic partnerships to enhance its market position in the maternal and infant sector, particularly through the launch of the "Dashi Shuyu" store in Jinan, which integrates various health-related products and services [1] Group 1: Company Strategy - The company is responding positively to national policies, particularly the "child-rearing subsidy" policy, to capture growth opportunities in the maternal and infant market [1] - A strategic partnership with Taiwan's Dashi Pharmacy has been established to create the "Dashi Shuyu" store, marking a significant step in the company's health service layout [1] Group 2: Product Offering - The "Dashi Shuyu" store focuses on user needs and aims to build a comprehensive ecosystem that includes professional pharmaceuticals, maternal and infant products, health products, and selected cross-border goods [1] - The store is designed to provide consumers with a more comprehensive and convenient health living solution [1]

Group 1 - The stock price of Shuyupingmin (301017) closed at 13.29 yuan on August 1, 2025, with an increase of 1.61% and a turnover rate of 3.43% [1] - The company reported a total revenue of 2.379 billion yuan for Q1 2025, a year-on-year decrease of 2.48%, while the net profit attributable to shareholders was 25.6239 million yuan, showing a year-on-year increase of 143.85% [1] - The company's liquidity ratios are as follows: current ratio at 0.959, quick ratio at 0.594, and debt-to-asset ratio at 77.16% [1] Group 2 - Shuyupingmin has made investments in 63 companies and participated in 144 bidding projects [2] - The company holds 452 trademark registrations and 7 patents, along with 46 administrative licenses [2]

Core Viewpoint - The community cultural festival in Jinan's Lixia District successfully engaged residents through various performances and services, highlighting the importance of community involvement and support for the elderly [2][3][4][5][6] Group 1: Community Engagement - The "Anti-Fraud Grandma Group," consisting of members averaging over 67 years old, performed skits to educate residents about common fraud tactics, effectively combining entertainment with important safety messages [3] - The festival featured a variety of performances, including clown acts and magic shows, which created a lively atmosphere and encouraged community participation [4] Group 2: Health and Wellness Services - A free health check-up station was set up by a local pharmacy, offering blood pressure, blood sugar, and bone density tests, which were well-received by the elderly residents [5] - Community members expressed satisfaction with the convenience of having health services available locally, allowing them to address minor health issues without needing to visit a hospital [5] Group 3: Future Plans - The community cultural festival is set to expand, with plans to reach 30 communities in Shandong Province by 2025, aiming to showcase the progress in building harmonious communities [6]

医药商业板块震荡走高，人民同泰（600829）拉升涨停，华人健康（301408）、塞力医疗（603716）、 漱玉平民（301017）、药易购（300937）跟涨。 ...

| 证券代码：301017 | 证券简称：漱玉平民 | 公告编号：2025-067 | | --- | --- | --- | | 债券代码：123172 | 债券简称：漱玉转债 | | 漱玉平民大药房连锁股份有限公司 关于持股 5%以上股东部分股份解除质押的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或者重大遗漏。 漱玉平民大药房连锁股份有限公司（以下简称"公司"）于近日收到公司持股 5%以上股 东秦光霞女士的通知，获悉其所持有公司的部分股份办理了解除质押业务，具体事项如下： 一、股东股份解除质押基本情况 （一）本次解除质押基本情况 | 股东 | 是否为控 股股东或 第一大股 | 本次解除 质押股份 | 占其所 持股份 | 占公司 总股本 | 起始日 | 解除日期 | 质权人 | | --- | --- | --- | --- | --- | --- | --- | --- | | 名称 | 东及其一 | 数量（股） | 比例 | 比例 | | | | | | 致行动人 | | （%） | （%） | | | | | 秦光霞 | 否 | 4,610,000 | ...

触及 1%整数倍暨减持计划实施完毕的公告 公司持股 5%以上股东、董事、高级管理人员秦光霞女士保证向本公司提供的信息内容真实、 准确、完整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈 述或者重大遗漏。 特别提示： 1、本次权益变动为持股 5%以上股东、董事、高级管理人员秦光霞女士实施之前披露的 减持股份计划导致的变动，不涉及要约收购。 | 证券代码：301017 | 证券简称：漱玉平民 | 公告编号：2025-066 | | --- | --- | --- | | 债券代码：123172 | 债券简称：漱玉转债 | | 漱玉平民大药房连锁股份有限公司 关于持股 5%以上股东、董事、高级管理人员权益变动比例 2、本次权益变动后，持股 5%以上股东、董事、高级管理人员秦光霞女士的股份由变动 前的 67,047,000 股减少至 61,369,900 股，占公司总股本的比例从 16.66%减少至 15.25%。 3、本公告中计算相关比例、数量时，总股本均为剔除公司回购专用账户股份后的股份 数量。 漱玉平民大药房连锁股份有限公司（以下简称"公 ...